Author Archives: Peter Megdal PhD

The Interplay of Apolipoprotein B and Systemic Inflammation in Atherosclerotic Cardiovascular Disease: Causality, Mechanisms, and Clinical Paradigms. Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of morbidity and mortality worldwide. For decades, the field debated the fundamental pathophysiological nature of atherogenesis.
For decades, the public has been told that a daily glass of wine might be the secret to longevity. This belief largely stems from the so-called J-shaped curve—a statistical pattern suggesting that light drinkers experience better cardiovascular outcomes than both heavy drinkers and people who abstain entirely. The implication was comforting: a little alcohol could be protective.
Most people think there’s one perfect diet for a long life. But emerging science suggests something far more interesting: the rules of healthy eating actually change as we age. What protects you at 45 may not protect you at 85. Longevity isn’t about sticking to the same nutrition plan forever — it’s about adapting to your body’s shifting biology. And according to new research, age 65 appears to be a major turning point.
The identification of individuals at extreme risk for atherosclerotic cardiovascular disease (ASCVD) and sudden cardiac death (SCD) has transitioned from a reliance on population-based probability models to a more granular, individualistic assessment of genetic architecture. Central to this transition is the "gene dosing" model of inheritance, which provides a quantitative framework for understanding how the accumulation of pathogenic alleles within a family unit correlates with the temporal onset of clinical disease.
Receive the latest news

Subscribe To Our Newsletter

Get notified about new articles.